Rad23B Antibodies

Santa Cruz Biotechnology provides a broad selection of Rad23B monoclonal antibodies for investigating cellular processes. Rad23B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rad23B plays a crucial role in the nucleotide excision repair pathway, maintaining genomic stability by facilitating DNA damage repair. The protein's involvement extends to regulating proteasomal degradation, which influences protein turnover and cellular homeostasis. Research focusing on Rad23B has revealed significant implications for understanding DNA repair mechanisms and cellular responses to stress. This knowledge continues to drive advances in cancer research and therapeutic development. Scientists worldwide rely on Rad23B monoclonal antibodies to explore DNA repair pathways and cellular stress responses. Understanding Rad23B functions has opened new avenues in cancer biology and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of DNA repair mechanisms and cellular homeostasis.